Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

C9ORF72 GGGGCC expanded repeats produce splicing dysregulation which correlates with disease severity in amyotrophic lateral sclerosis [HuEx-1_0-st]


ABSTRACT: Objective: An intronic GGGGCC-repeat expansion of C9ORF72 is the most common genetic variant of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia. The mechanism of neurodegeneration is unknown, but a direct effect on RNA processing mediated by RNA foci transcribed from the repeat sequence has been proposed. Results: Gene level analysis revealed a number of differentially expressed networks and both cell types exhibited dysregulation of a network functionally enriched for genes encoding ‘RNA splicing’ proteins. There was a significant overlap of these genes with an independently generated list of GGGGCC-repeat protein binding partners. At the exon level, in lymphoblastoid cells derived from C9ORF72-ALS patients splicing consistency was lower than in lines derived from non-C9ORF72 ALS patients or controls; furthermore splicing consistency was lower in samples derived from patients with faster disease progression. Frequency of sense RNA foci showed a trend towards being higher in lymphoblastoid cells derived from patients with shorter survival, but there was no detectable correlation between disease severity and DNA expansion length. Significance: Up-regulation of genes encoding predicted binding partners of the C9ORF72 expansion is consistent with an attempted compensation for sequestration of these proteins. A number of studies have analysed changes in the transcriptome caused by C9ORF72 expansion, but to date findings have been inconsistent. As a potential explanation we suggest that dynamic sequestration of RNA processing proteins by RNA foci might lead to a loss of splicing consistency; indeed in our samples measurement of splicing consistency correlates with disease severity. Gene expression profiling utilised total RNA extracted from lymphoblastoid cell lines derived from human ALS patients (n=56), and controls (n=15). Thirty-one of the ALS patients had a mutation of C9ORF72.

ORGANISM(S): Homo sapiens

SUBMITTER: Paul Heath 

PROVIDER: E-GEOD-68607 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2015-05-08 | E-GEOD-68605 | biostudies-arrayexpress
2015-05-08 | GSE68607 | GEO
2015-05-08 | GSE68605 | GEO
2013-11-07 | E-GEOD-52202 | biostudies-arrayexpress
2013-11-12 | E-GEOD-51684 | biostudies-arrayexpress
2013-11-07 | GSE52202 | GEO
2024-12-08 | GSE283702 | GEO
2013-11-12 | GSE51684 | GEO
2024-08-23 | GSE248404 | GEO
2016-02-10 | E-GEOD-77720 | biostudies-arrayexpress